如可从图8A和图8I看出，更多的突变基因可被患有肺癌的患者的动脉CTC

As can be seen from Figure 8A and Figure 8I, more mutated genes can be detected by the arterial CTC of patients with lung cancer. Compared with tissue and venous CTC, only arterial CTC can be used for mutated genes with clinically targeted drugs. detected;

As can be seen from Figures 8A and 8I, more mutant genes can be detected by arterial CTC in patients with lung cancer, relative to tissue and intravenous CTC, and mutant genes with clinically targeted medication can only be detected by arterial CTC;

As can be seen from figure 8a and figure 8i, more mutated genes can be detected by arterial CTC of patients with lung cancer. Compared with tissue and venous CTC, only arterial CTC can detect mutated genes with clinical targeted drugs;<br>